News & Articles

Results per page

Selected Filters:

Avacta Group plc Clear Filters

Industry News

Avacta’s proprietary TMAC cancer therapy platform demonstrates successful proof-of-concept in pre-clinical study

3 Feb 2020

Industry News

Avacta and Daewoong Pharmaceutical form immunotherapy focused joint venture

8 Jan 2020

Industry News

LG Chem Life Sciences Expands Partnership with Avacta Group plc

18 Nov 2019

Industry News

Avacta enters into collaboration and option agreement with ADC Therapeutics

10 Oct 2019

Product News

Avacta and Selexis Partner to Develop Cell Line for Clinical Manufacturing

23 Jun 2019

Industry News

Avacta and LG Chem Life Sciences Agree Multi-Target Affimer Therapeutics Development Alliance

11 Dec 2018

Industry News

Avacta Agrees Affimer Reagent Licensing Deal with New England Biolabs

16 Oct 2018

Product News

Avacta Group and Tufts University Collaborate to Develop Novel Drug Conjugate

24 Jul 2018

News & Articles

Articles Filter

Search

Selected Filters:

Avacta’s proprietary TMAC cancer therapy platform demonstrates successful proof-of-concept in pre-clinical study

Avacta and Daewoong Pharmaceutical form immunotherapy focused joint venture

LG Chem Life Sciences Expands Partnership with Avacta Group plc

Avacta enters into collaboration and option agreement with ADC Therapeutics

Avacta and Selexis Partner to Develop Cell Line for Clinical Manufacturing

Avacta and LG Chem Life Sciences Agree Multi-Target Affimer Therapeutics Development Alliance

Avacta Agrees Affimer Reagent Licensing Deal with New England Biolabs

Avacta Group and Tufts University Collaborate to Develop Novel Drug Conjugate

News & Articles

Articles FilterArticles Filter

Search

Selected Filters:

Avacta’s proprietary TMAC cancer therapy platform demonstrates successful proof-of-concept in pre-clinical study

Avacta and Daewoong Pharmaceutical form immunotherapy focused joint venture

LG Chem Life Sciences Expands Partnership with Avacta Group plc

Avacta enters into collaboration and option agreement with ADC Therapeutics

Avacta and Selexis Partner to Develop Cell Line for Clinical Manufacturing

Avacta and LG Chem Life Sciences Agree Multi-Target Affimer Therapeutics Development Alliance

Avacta Agrees Affimer Reagent Licensing Deal with New England Biolabs

Avacta Group and Tufts University Collaborate to Develop Novel Drug Conjugate

Articles Filter